Heterozygotes for Tangier disease possess structurally normal HDL particles but at half the normal concentration, accompanied by tissue lipid storage.
No takes yet. Share an insight, caveat, or question.
Does not support changing management in Tangier heterozygotes; leaves open cardiovascular consequences of reduced HDL mass.
Assmann et al. (1977) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: